117 related articles for article (PubMed ID: 35192293)
21. Chromogranin A Expression in Rectal Neuroendocrine Tumors Is Associated With More Aggressive Clinical Behavior and a Poorer Prognosis.
Kim J; Kim JY; Oh EH; Yoo C; Park IJ; Yang DH; Ryoo BY; Ryu JS; Hong SM
Am J Surg Pathol; 2020 Nov; 44(11):1496-1505. PubMed ID: 32735108
[TBL] [Abstract][Full Text] [Related]
22. [Clinicopathological features and multivariate analysis of prognostic factors for patients with gastroenteropancreatic neuroendocrine tumors].
Wang X; Song ZF; Yao WX; Pan CC; Xiang MF; Wang H
Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1411-4. PubMed ID: 24025507
[TBL] [Abstract][Full Text] [Related]
23. Number of Positive Lymph Nodes Is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms.
Gao B; Zhou D; Qian X; Jiang Y; Liu Z; Zhang W; Wang W
Front Endocrinol (Lausanne); 2021; 12():613755. PubMed ID: 33746899
[TBL] [Abstract][Full Text] [Related]
24. Lymphovascular Invasion Is Associated with Lymph Node Involvement in Small Appendiceal Neuroendocrine Tumors.
Blakely AM; Raoof M; Ituarte PHG; Fong Y; Singh G; Lee B
Ann Surg Oncol; 2019 Nov; 26(12):4008-4015. PubMed ID: 31359272
[TBL] [Abstract][Full Text] [Related]
25. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.
Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK
Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
27. Validated Risk-Score Model Predicting Lymph Node Metastases in Patients with Non-Functional Gastroenteropancreatic Neuroendocrine Tumors.
Shannon AB; Straker RJ; Fraker DL; Miura JT; Karakousis GC
J Am Coll Surg; 2022 May; 234(5):900-909. PubMed ID: 35426404
[TBL] [Abstract][Full Text] [Related]
28. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.
Xu Z; Wang L; Dai S; Chen M; Li F; Sun J; Luo F
JAMA Netw Open; 2021 Sep; 4(9):e2124750. PubMed ID: 34554237
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
[No Abstract] [Full Text] [Related]
30. Prognostic Effect of Lymph Node Metastases and Mesenteric Deposits in Neuroendocrine Tumors of the Small Bowel.
Grillo F; Albertelli M; Malandrino P; Dotto A; Pizza G; Cittadini G; Colao A; Faggiano A
J Clin Endocrinol Metab; 2022 Nov; 107(12):3209-3221. PubMed ID: 35639999
[TBL] [Abstract][Full Text] [Related]
31. The number of positive lymph node is a better predictor of survival than the lymph node metastasis status for pancreatic neuroendocrine neoplasms: A retrospective cohort study.
Zhang X; Lu L; Shang Y; Liu P; Wei Y; Ma L; Gong P
Int J Surg; 2017 Dec; 48():142-148. PubMed ID: 29107188
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptors 1-9 in small bowel neuroendocrine tumors-Clinical significance and prognosis.
Hiltunen N; Kemi N; Väyrynen JP; Böhm J; Kauppila JH; Huhta H; Helminen O
PLoS One; 2024; 19(5):e0302813. PubMed ID: 38709790
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of three lymph node staging systems in predicting overall survival for gastric cancer patients after radical resection].
Luo C; Zhang G; Wang W; Zhou Z; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1107-1112. PubMed ID: 27781245
[TBL] [Abstract][Full Text] [Related]
34. Colon Neuroendocrine Tumors: A New Lymph Node Staging Classification.
Fields AC; McCarty JC; Lu P; Vierra BM; Pak LM; Irani J; Goldberg JE; Bleday R; Chan J; Melnitchouk N
Ann Surg Oncol; 2019 Jul; 26(7):2028-2036. PubMed ID: 30927196
[TBL] [Abstract][Full Text] [Related]
35. A Lymph Node Ratio-Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine Tumors.
Gaitanidis A; Patel D; Nilubol N; Tirosh A; Kebebew E
J Clin Endocrinol Metab; 2018 Jan; 103(1):187-195. PubMed ID: 29069375
[TBL] [Abstract][Full Text] [Related]
36. The stratification of positive lymph nodes into pN1 and pN2 for upper urinary tract carcinoma is not prognostically significant.
Wu DJ; Wong MN; Lee CT; Zynger DL
Hum Pathol; 2023 Jul; 137():48-55. PubMed ID: 37088434
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathological classification and prognostic factors of gastrointestinal neuroendocrine neoplasms: an analysis of 119 cases].
Ma X; Zhao W; Zhuang C; Wang X; Tu L; Wang M; Sun Y; Cao H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):997-1001. PubMed ID: 28900989
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
[No Abstract] [Full Text] [Related]
39. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine tumors: analysis from a single-institution.
Zeng YJ; Liu L; Wu H; Lai W; Cao JZ; Xu HY; Wang J; Chu ZH
Asian Pac J Cancer Prev; 2013; 14(10):5775-81. PubMed ID: 24289577
[TBL] [Abstract][Full Text] [Related]
40. [Pathological staging criteria for carcinoma in the remnant stomach: an exploratory study].
Gao Z; Zhao X; Jiang K; Wang B; Li Y; Ye Y; Wang S
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):514-521. PubMed ID: 29774932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
